During the past decade, Fundação Antônio Prudente - A.C. Camargo Cancer Center conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 17 clinical trials were completed, i.e. on average, 28.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 10 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" #1 sponsor was "AC Camargo Cancer Center" with 16 trials, followed by "Janssen Research & Development, LLC" with 14 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Latin American Cooperative Oncology Group" with 4 trials sponsored and "Merck Sharp & Dohme LLC" with 4 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator and "A Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 49 trials.

According to Clinical.Site data, the most researched conditions in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" are "Breast Cancer" (7 trials), "Carcinoma, Non-Small-Cell Lung" (6 trials), "Prostatic Neoplasms" (4 trials), "Gastric Cancer" (3 trials) and "Multiple Myeloma" (3 trials). Many other conditions were trialed in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" in a lesser frequency.

Most popular intervention types in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" are "Drug" (48 trials), "Other" (7 trials), "Radiation" (6 trials), "Biological" (4 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Trastuzumab" (6 trials), "Amivantamab" (5 trials), "Dexamethasone" (5 trials) and "Carboplatin" (4 trials). Other intervention names were less common.

The vast majority of trials in "Fundação Antônio Prudente - A.C. Camargo Cancer Center" are 59 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Fundação Antônio Prudente - A.C. Camargo Cancer Center". undefined are not yet recruiting, 22 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Fundação Antônio Prudente - A.C. Camargo Cancer Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Fundação Antônio Prudente - A.C. Camargo Cancer Center, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".

Fundação Antônio Prudente - A.C. Camargo Cancer Center has several departments that took part in Clinical trials: "A. C. Camargo Cancer Center" - 2 trials, "Fundação NAtonio Prudente (AC Camargo Cancer Center)" - 2 trials